RPS6 and urinary bladder carcinoma: In conclusion, in addition to the effects of amiodarone on AKT, the drug consistently reduced p-mTOR and p-S6 in the four bladder cancer cell lines, suggesting that the anticancer effect of amiodarone in bladder cancer is mediated by the inhibition of mTOR.